Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma
CONCLUSION: FGF23 was highly expressed in US and was promising as a novel potential biomarker for the diagnosis and prognosis of US.PMID:38613349 | DOI:10.1177/15330338241245924
Source: Technology in Cancer Research and Treatment - Category: Cancer & Oncology Authors: Ling Yang Ying Cai Yunjia Wang Yue Huang Chi Zhang Hu Ma Jian-Guo Zhou Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinosarcoma | Genetics | Leiomyoma | Sarcomas | Study | Uterine Sarcoma | Women